Laboratory errors in the measurement of spectrin levels: detection range

References (10)

1. Cetin I, Demirel OF. Increased serum levels of spectrin degradation products in patients with schizophrenia. Turk J Biochem 2018;43:22–9
2. MyBioSource Inc. Human alpha II-spectrin breakdown products SBDP120 (SBDP120) ELISA Kit. San Diego, USA
3. MyBioSource Inc. Human alpha II-spectrin breakdown products SBDP145 (SBDP145) ELISA Kit. San Diego, USA
4. Taylor JK. Quality assurance of chemical measurements. Chelsea, MI: Lewis Publishers, 1987
5. Croghan C. Egeghy PP. Methods of Dealing with Values Below the Limit of Detection using SAS. Presented at Southeastern SAS User Group, St. Petersburg, FL, September 22–24, 2003
6. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008;29:49–52
7. Wood MD, Beresford NA, Copplestone D. Limit of detection values in data analysis: do they matter? Radioprotection 2011;46:85–90
8. Pritt ML, Hall DG, Jordan WH, Ballard DW, Wang KK, Müller UR, et al. Initial biological qualification of SBDP-145 as a biomarker of compound-induced neurodegeneration in the rat. Toxicol Sci 2014;141:398–408
9. Jain P, Spaeder MC, Donofrio MT, Sinha P, Jonas RA, Levy RJ. Detection of alpha II-spectrin breakdown products in the serum of neonates with congenital heart disease*. Pediatr Crit Care Med 2014;15:229–35
10. Farkas O, Polgár B, Szekeres-Barthó J, Dóczi T, Povlishock JT, Büki A. Spectrin breakdown products in the cerebrospinal fluid in severe head injury–preliminary observations. Acta Neurochir (Wien) 2005;147:855–61.